About: Willem Weimar

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Willem Weimar Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) researcher (en) ricercatore (it) 研究者 (ja) дослідник (uk) वैज्ञानिक (hi) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy) onderzoeker (nl)
rdfs:label	Willem Weimar (en) Willem Weimar (es) Willem Weimar (nl) Willem Weimar (ast)
skos:prefLabel	Willem Weimar (en) Willem Weimar (es) Willem Weimar (nl) Willem Weimar (ast)
name	Willem Weimar (en) Willem Weimar (es) Willem Weimar (nl) Willem Weimar (ast)
given name	wds:Q64124006-AB2F272C-BC11-4437-84C0-E39237DC656A
given name	Willem
instance of	wds:Q64124006-7E6D4F9E-8876-46F6-AD4D-A3AB87E2F80B
instance of	Homo sapiens
occupation	wds:Q64124006-A2A0559F-AC9B-4F77-96FD-78E2A4D9AA7E
sex or gender	wds:Q64124006-04D0FD9F-1B4D-4453-892A-5FE4631F288B
VIAF ID	wds:Q64124006-BFACFB00-A14B-4A29-B80F-FD6A08B82B7D
WorldCat Identities ID (superseded)	wds:Q64124006-03DF09AD-30AB-4291-A0BC-3025576E039E
National Library of Israel J9U ID	wds:Q64124006-469BA183-0480-4DE2-B526-46FC5FF21EA1
VIAF ID	http://viaf.org/viaf/75060645
occupation	researcher
sex or gender	male
VIAF ID	75060645
WorldCat Identities ID (superseded)	lccn-no2009045266
National Library of Israel J9U ID	987007431054705171
ORCID iD	wds:Q64124006-61BB7469-3502-42D3-9A18-EFBFAD54EE98
ORCID iD	https://orcid.org/0000-0003-0352-4259
ORCID iD	0000-0003-0352-4259
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64124006
is author of	Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients Mesenchymal stem cells induce an inflammatory response after intravenous infusion. The functional polymorphism Ala258Ser in the innate receptor gene ficolin-2 in the donor predicts improved renal transplant outcome. Current immunosuppressive treatment after kidney transplantation Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus Modifiable factors in access to living-donor kidney transplantation among diverse populations Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responses. Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study No important influence of limited steroid exposure on bone mass during the first year after renal transplantation: a prospective, randomized, multicenter study Comparison of laparoscopic and mini incision open donor nephrectomy: single blind, randomised controlled clinical trial Phosphospecific flow cytometry for pharmacodynamic drug monitoring: analysis of the JAK-STAT signaling pathway Seriously ill patients as living unspecified kidney donors: rationale and justification. End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells A plea for uniform European definitions for organ donor potential and family refusal rates. Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2. Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes. Risk factors associated with encapsulating peritoneal sclerosis in Dutch EPS study Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive In vitro and in a Humanized Allograft Rejection Model. Incentives for organ donation: proposed standards for an internationally acceptable system FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients Hepatitis E virus infection among solid organ transplant recipients, the Netherlands Ischemic postconditioning in human DCD kidney transplantation is feasible and appears safe. Fundamental role for HO-1 in the self-protection of renal allografts. Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation Functional heme oxygenase-1 promoter polymorphism in relation to heart failure and cardiac transplantation. More than a decade after live donor nephrectomy: a prospective cohort study Living organ donation practices in Europe - results from an online survey Randomized controlled trial comparing hand-assisted retroperitoneoscopic versus standard laparoscopic donor nephrectomy. Quality of life of elderly live kidney donors. Psychosocial and physical impairment after mini-incision open and laparoscopic donor nephrectomy: A prospective study. Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin The Hague Recommendations: Improving Nonlegislative Responses to Trafficking in Human Beings for the Purpose of Organ Removal Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation Living donor kidney transplantation among ethnic minorities in the Netherlands: a model for breaking the hurdles. Accumulation of unfavorable clinical and socioeconomic factors precludes living donor kidney transplantation. Complex vascular anatomy in live kidney donation: imaging and consequences for clinical outcome On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation Incentives for living kidney donation: what does the public think? Avoiding the issue: patients' (non)communication with potential living kidney donors Genetic variants of FOXP3 influence graft survival in kidney transplant patients Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T > C polymorphism Quantifying the benefit of early living-donor renal transplantation with a simulation model of the Dutch renal replacement therapy population. Regulatory T cells in alloreactivity after clinical heart transplantation Down-Regulation of Surface CD28 under Belatacept Treatment: An Escape Mechanism for Antigen-Reactive T-Cells Differential intragraft cytokine messenger RNA profiles during rejection and repair of clinical heart transplants. A longitudinal study. Regulatory T cells after organ transplantation: where does their action take place? Inadequate immune regulatory function of CD4+CD25bright+FoxP3+ T cells in heart transplant patients who experience acute cellular rejection. Laparoscopic donor nephrectomy: a plea for the right-sided approach Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil Inosine monophosphate dehydrogenase messenger RNA expression is correlated to clinical outcomes in mycophenolate mofetil-treated kidney transplant patients, whereas inosine monophosphate dehydrogenase activity is not. Yersinia pseudotuberculosis bacteraemia in a kidney transplant patient

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software